IgG Cleaving Enzymes as a Potential Solution to the NAb Challenge

Time: 1:00 pm
day: Day 1 Track B PM


  • An overview of Imlifidase: it’s MOA and translatability for use in conjunction with gene therapies
  • Analyzing data from its use in in-human gene therapy trials
  • Considerations for treatment timing and dosing post-adminstration